Hi Husker:
Those are very interesting very long term prospects, but i am too old and have been over invested in ADXS too long to wait for FDA approval on Neo and infectious diseases.
Further, if past performance is any indication, the patents will run out on those too before we get to market, if they prove successful against considerable odds.
We have invested a huge amount into the vaccines currently in clinical trials and they represent most of the value the company has in my eyes.
You infer they are nearly worthless.
Please explain that and how patents don't age?